EDGE THERAPEUTICS, INC. 10-K 12-31-2015

Company

PDS Biotechnology Corp

Filed

March 8, 2016

Period of Report

December 31, 2015

Accession Number

0001140361-16-056994

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →